Search

everythinglearnresearchcommunity

for

Search:↓

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

The oral contraceptive improved hair and skin quality in women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Finasteride may improve sperm count in subfertile men with low sperm count.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Early balding linked to higher heart disease risk.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Malassezia yeast might be linked to more hair shedding.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

High uric acid levels link to male pattern baldness, especially in young men.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.